Streptococci, Enterococci Flashcards
Diagnosis of S.Pyogens Group A
Gram (+) cocci, catalase (-), β-haemolytic
–> on blood agar
Transmission of S.Pyogens Group A
Droplets, colonizes throat
Pathogenesis/Vf of S.Pyogens Group A
M-proteins –> associated with RF
Pyrogenic exotoxins –> causes Scarlet fever
Clinical Manifestations of S.pyogens Group A
1) Pharyngitis, Scarlet Fever: strawberry tongue, rash (exp.face), pharyngitis
2) Suppurative:
- impetigo,
- eryspiles,
- cellulitis,
- necrotizing fasciitis (streptococcal gangrene)
- streptococcal TSS (Toxic shock syndrome not associated with tampons )
3) Non-Suprative:
- RF (pancarditis, skin nodules, erythema marginatum, migratory arthritis, Sydenham’s chorea, increases inflm. markers (ESR,CRP), Rheumatic heart disease)
- Post-streptococcal glomerulonephritis (10d after GAS pharyngitis or 3wks after pyoderma)
Test for Post-streptococcal glomerulonephritis
Urine dipstick–> dark-brown urine containing protein & RBC
Treatment for S.pyogens Group A
Penicillin to eradicate nephrogenic GAS strains
Diagnosis of S. agalactiae Group B
Gram (+) cocci, catalse (-), β-hemolytic
Infection route of of S.agalactiae Group B
–> colonizes the lower GI tract & genitourinary tract
–> neonates: GBS colonized mother
clinical Manifestations of S.agalactiae Group B
Neonates:
1) Bacteraemia
2) Pneumonia
3) Meningitis & sepsis
Treatment for S.agalactiae Group A
–> test pregnant women (RCR for Rectal &vaginal swabs) at 35 wks
–> give mother penicillin as prophylaxis
Diagnosis of Viridians Streptococci
gram (+) cocci, catalse (-), α-heamolytic & non-heamolytic
–> Optochin resistant
–> Bile resistant
Infection route of S.Viridians
colonizes the oropharynx, GI & genitourinary tract
clinical Manifestaions of S.Viridians
1) endocarditis after dental manipulation
2) Bacteremia in hematology patients receiving chemo (oral mucositis)
3) If S.bovis (S.gallolyticus) BSI= search for colon cancer
4) Aspiration pneumonia, abscesses formation
pathogenesis/Vf of S.pneumonia
Virulent strains have polysaccharide capsule
–> IgA proteases
–> pneumolysin (its VF can damage human antibodies)
clinical Manifestaions of S.pneumonia
1) >39 °C fever
2) cough
3) bloody and purulent sputum
4)dyspnoea
5) chest pain
6) Bacteremia
7) sinusitis
8) otitis media
9) meningitis
*MOPS: Meningitis, Otitis media, Pneumonia, and Sinusitis are the no.1 cause of S.pneumonia
Treatment of S.pneumonia
Adult vaccine PPSV-23 (IgM)
Infant Vaccine PCV-13 (IgG)
Diagnosise of Enterococci
gram (+), catalase (-), coagulase (+), γ- or α-heamolytic, aerobic & anaerobic
–> Bile resistant
Infection route of Enterococci
colonizes Human intestine
Pathogenesis/VF of Enterococci
Biofilm, Abx resistance (Carbapenem resistant)
Clinical manifestation of Enterococci
1) Bacteremia with and without endocarditis
2) CA-BSI
3)HA-BASI
4) HA-UTI
5)diabetic foot ulcer
6)decubitus ulcer w/ faecal material
Resistant phenotype of Enterococci and Treatment
Vacomycin resisatnt enterococci (VRE)
treatment (drugs): tigecycline, linezolid
Diagnosis of Streptoc0ccus pneumonia
Gram (+) diplococcus, catalase (-)
- α-haemolytic
- Optochin sensitive
- Soluble in bile salts
Risk factors of S.pneumonia
1) Extremes of age
2) smoking / chronic lung disease
3) splenectomy
4) HIV
5) Haematological B-cell and other malignancies
6) immunosuppressive medications &solid tumours
7) diabetes, chronic liver, kidney, lung & heart disease & alcoholism
8) low complement & hypoglobulinemia